Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Incidence of inflammatory joint diseases in Finland: results from a population-based epidemiological study.

Kononoff A, Arstila L, Pussinen P, Kautiainen H, Elfving P, Savolainen E, Niinisalo H, Rutanen J, Marjoniemi O, Kaipiainen-Seppänen O.

Rheumatol Int. 2017 Aug 8. doi: 10.1007/s00296-017-3779-1. [Epub ahead of print]

PMID:
28791449
2.

Profile of initial drug therapy in paediatric systemic lupus erythematosus in Finland, 2000-2007.

Elfving P, Puolakka K, Kautiainen H, Virta LJ, Pohjolainen T, Kaipiainen-Seppänen O.

Clin Exp Rheumatol. 2017 Mar-Apr;35(2):352. Epub 2017 Jan 15. No abstract available.

PMID:
28094755
3.

Estimating the incidence of connective tissue diseases and vasculitides in a defined population in Northern Savo area in 2010.

Elfving P, Marjoniemi O, Niinisalo H, Kononoff A, Arstila L, Savolainen E, Rutanen J, Kaipiainen-Seppänen O.

Rheumatol Int. 2016 Jul;36(7):917-24. doi: 10.1007/s00296-016-3474-7. Epub 2016 Apr 6.

PMID:
27053177
4.

Drugs used in incident systemic lupus erythematosus - results from the Finnish nationwide register 2000-2007.

Elfving P, Puolakka K, Kautiainen H, Virta LJ, Pohjolainen T, Kaipiainen-Seppänen O.

Lupus. 2016 May;25(6):666-70. doi: 10.1177/0961203316628998. Epub 2016 Jan 27.

PMID:
26821964
5.

Impact of quality indicators on adherence to National and European guidelines for renal cell carcinoma.

Thorstenson A, Harmenberg U, Lindblad P, Ljungberg B, Lundstam S; Swedish Kidney Cancer Quality Register Group.

Scand J Urol. 2016;50(1):2-8. doi: 10.3109/21681805.2015.1059882. Epub 2015 Jul 23.

PMID:
26202573
6.

Automated immunoassays for the autoantibodies to carbamylated or citrullinated telopeptides of type I and II collagens.

Häyrynen J, Kärkkäinen M, Kononoff A, Arstila L, Elfving P, Niinisalo H, Savolainen E, Kautiainen H, Risteli J, Kaipiainen-Seppänen O, Koivula MK.

Clin Chem Lab Med. 2015 Aug;53(9):1375-80. doi: 10.1515/cclm-2014-0683.

PMID:
25389994
7.

Incidence of systemic lupus erythematosus in Finland, 2000-2007, a nationwide study.

Elfving P, Puolakka K, Kautiainen H, Virta LJ, Pohjolainen T, Kaipiainen-Seppänen O.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6):953-5. Epub 2014 Oct 20.

PMID:
25328038
8.

Mortality and causes of death among incident cases of systemic lupus erythematosus in Finland 2000-2008.

Elfving P, Puolakka K, Kautiainen H, Virta LJ, Pohjolainen T, Kaipiainen-Seppänen O.

Lupus. 2014 Nov;23(13):1430-4. doi: 10.1177/0961203314543919. Epub 2014 Jul 23.

PMID:
25057036
9.

Five cases of interstitial lung disease after leflunomide was combined with methotrexate therapy.

Rutanen J, Kononoff A, Arstila L, Elfving P, Koskela H, Kaipiainen-Seppänen O.

Scand J Rheumatol. 2014;43(3):254-6. doi: 10.3109/03009742.2013.868511. Epub 2014 Mar 21. No abstract available.

PMID:
24650220
10.

Sarcomatoid conversion of clear cell renal cell carcinoma in relation to epithelial-to-mesenchymal transition.

Boström AK, Möller C, Nilsson E, Elfving P, Axelson H, Johansson ME.

Hum Pathol. 2012 May;43(5):708-19. doi: 10.1016/j.humpath.2011.06.019. Epub 2011 Oct 10.

PMID:
21992819
11.

High-resolution genomic profiling of an adult Wilms' tumor: evidence for a pathogenesis distinct from corresponding pediatric tumors.

Karlsson J, Holmquist Mengelbier L, Elfving P, Gisselsson Nord D.

Virchows Arch. 2011 Nov;459(5):547-53. doi: 10.1007/s00428-011-1148-0. Epub 2011 Sep 23.

PMID:
21947875
12.

Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.

Johansson E, Steineck G, Holmberg L, Johansson JE, Nyberg T, Ruutu M, Bill-Axelson A; SPCG-4 Investigators.

Lancet Oncol. 2011 Sep;12(9):891-9. doi: 10.1016/S1470-2045(11)70162-0. Epub 2011 Aug 5.

PMID:
21821474
13.

Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: evaluation of cardiovascular events in a randomized trial.

Hedlund PO, Johansson R, Damber JE, Hagerman I, Henriksson P, Iversen P, Klarskov P, Mogensen P, Rasmussen F, Varenhorst E; SPCG-5 STUDY GROUP.

Scand J Urol Nephrol. 2011 Nov;45(5):346-53. doi: 10.3109/00365599.2011.585820. Epub 2011 May 31.

PMID:
21627403
14.

[Adverse muscle effects of a podofyllotoxin-containing cytotoxic drug product with simvastatin].

Kaipiainen-Seppänen O, Savolainen E, Elfving P, Kononoff A.

Duodecim. 2009;125(7):788-91. Finnish.

PMID:
19432085
15.

Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.

Johansson E, Bill-Axelson A, Holmberg L, Onelöv E, Johansson JE, Steineck G; Scandinavian Prostate Cancer Group Study No 4.

Eur Urol. 2009 Feb;55(2):422-30. doi: 10.1016/j.eururo.2008.08.054. Epub 2008 Sep 2.

PMID:
18783877
16.

Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5.

Hedlund PO, Damber JE, Hagerman I, Haukaas S, Henriksson P, Iversen P, Johansson R, Klarskov P, Lundbeck F, Rasmussen F, Varenhorst E, Viitanen J; SPCG-5 Study Group.

Scand J Urol Nephrol. 2008;42(3):220-9. doi: 10.1080/00365590801943274.

PMID:
18432528
17.

Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer.

Soller MJ, Isaksson M, Elfving P, Soller W, Lundgren R, Panagopoulos I.

Genes Chromosomes Cancer. 2006 Jul;45(7):717-9. No abstract available.

PMID:
16575875
18.

Dissecting karyotypic patterns in renal cell carcinoma: an analysis of the accumulated cytogenetic data.

Höglund M, Gisselsson D, Soller M, Hansen GB, Elfving P, Mitelman F.

Cancer Genet Cytogenet. 2004 Aug;153(1):1-9.

PMID:
15325087
19.

Telomere shortening and mitotic dysfunction generate cytogenetic heterogeneity in a subgroup of renal cell carcinomas.

Gisselsson D, Gorunova L, Höglund M, Mandahl N, Elfving P.

Br J Cancer. 2004 Jul 19;91(2):327-32.

20.

Karyotypic characterization of urinary bladder transitional cell carcinomas.

Fadl-Elmula I, Gorunova L, Mandahl N, Elfving P, Lundgren R, Mitelman F, Heim S.

Genes Chromosomes Cancer. 2000 Nov;29(3):256-65.

PMID:
10992300

Supplemental Content

Loading ...
Support Center